Canada markets closed

Biofrontera Inc. (BFRI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0400+0.0590 (+6.01%)
At close: 04:00PM EST
1.0400 0.00 (0.00%)
After hours: 06:58PM EST

Biofrontera Inc.

120 Presidential Way
Suite 330
Woburn, MA 01801
United States

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees69

Key Executives

NameTitlePayExercisedYear Born
Dr. Hermann Lubbert Ph.D.Exec. Chairman & Pres18.02kN/A1956
Ms. Erica L. Monaco CPACEO, COO, Treasurer & Sec.402.12kN/A1985
Mr. Eugene Fredrick Leffler IIIChief Financial OfficerN/AN/A1984
Ms. Erica F. Gates CPA, M.B.A.Sr. Director of Fin. & Principal Accounting OfficerN/AN/AN/A
Ms. Alycia TorresVP of Admin.N/AN/AN/A
Mr. Daniel Hakansson J.D.Gen. Counsel & Head of ComplianceN/AN/AN/A
Mr. Mark BaldygaHead of Sales & MarketingN/AN/AN/A
Mr. Jeff HolmHead of Professional Relations & Commercial Devel.N/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was founded in 1997 and is headquartered in Woburn, Massachusetts.

Corporate Governance

Biofrontera Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.